Our Mission:
Engineering biology needs more than invention — it needs infrastructure.
At GitLife, we’re building the infrastructure for biological rights and IP management — helping biotech teams structure, protect, and commercialise their innovations from day one.
Just as digital rights management reshaped how software is owned and distributed, we believe synthetic biology needs tools that give innovators the same level of clarity, control, and commercial power. Our platform is designed to make biology traceable, shareable, and secure — so that every contribution becomes a protected, licensable asset.
Biological innovation is accelerating — but the systems to manage it haven’t kept pace. Teams still rely on spreadsheets, siloed records, and legal PDFs to track IP, often losing time, clarity, and value along the way. GitLife was created to change that. We believe that by embedding version control, licensing structure, and biosecurity into everyday biotech workflows, we can unlock a new era of secure, scalable collaboration in synthetic biology.
our story, so far...
GitLife Biotech’s journey has been marked by numerous exciting milestones that reflect our commitment to innovation, excellence, and collaboration.
From our incorporation to securing prestigious grants and forming valuable partnerships, our timeline highlights the rapid growth and significant achievements that have shaped our story.
Click around below to learn more about our journey so far and key milestones.
GitLife Biotech Incorporation
GitLife Biotech was officially incorporated, marking the beginning of our mission to set new standards in synthetic biology and biological asset management.
Spin Out from Newcastle University
GitLife spun out from Newcastle University, leveraging cutting-edge academic expertise to drive innovation in synthetic biology solutions and enhance transparency, essential for advancing engineering biology and managing intellectual property rights
First Fundraise Close
We successfully closed our first fundraising round, securing crucial resources to accelerate our research and development initiatives.
Investor Partnership Grant
We commenced our Investor Partnership Grant under the Future Economy Investor Partnerships SME Round 1 (Innovate UK), enhancing our capacity to develop cutting-edge technologies.
Tech Kickstarter 2.0 Competition Win & NCIMB Collaboration Grant
GitLife Biotech won the Tech Kickstarter 2.0 competition, showcasing our innovative solutions and solidifying our reputation as a leader in synthetic biology. Learn more.
Additionally, our collaboration grant with NCIMB started under the Engineering Biology Collaborative R&D Round 2 This partnership will see GitLife Biotech technology to securely barcode and organise biological data, linking it to our biosecurity platform Learn more.
Initial Team Expansion
We expanded our team by hiring a Molecular Microbiologist, Bioinformatician, and Policy & Regulatory Analyst, strengthening our team’s expertise and capabilities.
Participation in SynBioBeta 2024
Our team attended SynBioBeta 2024, a leading event for synthetic biology, where we showcased our latest innovations and networked with industry leaders. Learn more
Grand Scale Kickstart for ICURe
GitLife Biotech was selected for the Grand Scale Kickstart for ICURe, highlighting our potential to scale and significantly impact the synthetic biology sector.
Planned Team Expansion
By the end of 2024, we plan to further expand our team, bringing in more talent to drive our mission forward and achieve many new milestones in synthetic biology.
What we stand for
At GitLife, our values guide how we build, collaborate, and grow
They shape how we work — with customers, with each other, and with the future of biotech in mind
Honest, kind and clear communication
Do the right thing – and own it
Bold ideas, real world impact
People matter more than process
We grow by lifting each other
our team
GitLife brings together scientists, engineers, and operators with deep experience across synthetic biology, data infrastructure, and commercial strategy. We’re a small, ambitious team with deep roots in both lab science and real-world commercialisation — building the tools we wish we’d had.
working at GitLife
We’re building something ambitious — and we’re doing it with care.
We work remotely across disciplines and time zones, while staying closely connected to the lab. Our team is flexible and outcome-focused — we trust each other to manage time and work in ways that support deep focus, clear communication, and meaningful collaboration. Whether in person at our Newcastle base or online from anywhere, we make space for different working styles.
We move fast but thoughtfully. We’re transparent about what’s working and what’s not. And we’re always learning — together.
If that sounds like your kind of team, we’d love to hear from you.
join our journey
We’re building the tools to support the next generation of biotech founders, scientists, and commercial leads.
Careers: Our Current vacancies.
If there is no suitable role listed above, but you’d like to be considered for future vacancies, we’d love to hear from you!
